Mutual Fund Details

DSP Healthcare Fund Direct - Growth

Name: DSP Healthcare Fund Direct - Growth
Brand: DSP Mutual Fund

Equity Pharma

NAV

₹41.1980

as on 21 Feb 2025, 09:00 PM

₹-0.4430(1.06%)

Last Change

Scheme Ratings

Pharma

5Y Returns

rated by Value Research

Pharma

Rankings based on 5Y Returns | as on 18 Nov 2024

DSP Healthcare Fund Direct - Growth

26.80%

ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth

26.97%

Mirae Asset Healthcare Fund Direct - Growth

25.22%

SBI Healthcare Opportunities Fund Direct Plan-Growth

25.74%

UTI Healthcare Fund Direct-Growth

24.21%

Investment Performance

would have given a return of

₹1,10,871

₹1,21,647

₹1,78,831

₹1,86,239

Bank Account

Fixed Deposit

Regular Mutual Fund

This Fund on Paytm Money

This Mutual Fund

₹86,239

Profit (absolute return)

86.24%

in the last

max

+1% Higher Returns

With Direct Plans on Paytm Money

Investment Returns

In the last 3 months

7.20%

In the last 6 months

2.39%

In the last 1 year

15.25%

In the last 3 years

86.24%

In the last 5 years

224.75%

In the last 10 years

Absolute Returns

CAGR

Scheme Riskometer

low

low to moderate

moderate

moderately high

high

very high

Investors understand that their principal will be at very high risk

Scheme Information

DSP Healthcare Fund Direct - Growth

as of 31 Jan 2025, 05:30 AM

₹3,197.52 Cr

Scheme Asset Size

Fund Type

Open-End

Exit Load

Exit load of 0.50% if redeemed within 1 month.

0.58%

Expense Ratio

Plan

Growth

0.80%

Cash Holding

Benchmark

BSE Healthcare Total Return Index

Scheme Document

View

Benchmark

BSE Healthcare Total Return Index

Exit Load

Exit load of 0.50% if redeemed within 1 month.

Scheme Document

View

Sectors Holding in this Mutual Fund

as on 31 Jan 2025

Sort By

Value

Sector

Healthcare

97.12%

₹3,105.43 Cr

Insurance

1.40%

₹44.77 Cr

Cash Holding

0.80%

₹25.58 Cr

Others

0.68%

₹21.74 Cr

Sectors Holding in this Mutual Fund

as on 31 Jan 2025

Sort By

Value

Sector

Healthcare

97.12%

₹3,105.43 Cr

Insurance

1.40%

₹44.77 Cr

Cash Holding

0.80%

₹25.58 Cr

Others

0.68%

₹21.74 Cr

Companies Holding in this Mutual Fund

as on 31 Jan 2025

Sort By

Value

Company

Sun Pharmaceutical Industries Ltd.

12.50%

₹399.69 Cr

Suven Pharmaceuticals Ltd.

9.38%

₹299.93 Cr

Cipla Ltd.

8.28%

₹264.75 Cr

Ipca Laboratories Ltd.

7.31%

₹233.74 Cr

Lupin Ltd.

7.14%

₹228.30 Cr

Others

55.39%

₹1,771.11 Cr

View All

Companies Holding in this Mutual Fund

as on 31 Jan 2025

Sort By

Value

Company

Sun Pharmaceutical Industries Ltd.

12.50%

₹399.69 Cr

Suven Pharmaceuticals Ltd.

9.38%

₹299.93 Cr

Cipla Ltd.

8.28%

₹264.75 Cr

Ipca Laboratories Ltd.

7.31%

₹233.74 Cr

Lupin Ltd.

7.14%

₹228.30 Cr

Others

55.39%

₹1,771.11 Cr

View All

Funds in this Category

This fund's returns:

23.01%

Return Duration

3 Years

SBI Healthcare Opportunities Fund Direct Plan-Growth

ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth

Tata India Pharma & HealthCare Fund Direct-Growth

About DSP Healthcare Fund Direct - Growth

DSP Healthcare Fund Direct - Growth is a Equity mutual fund scheme from DSP Mutual Fund. This scheme was launched on Invalid date. It has an AUM of ₹3,197.52 Crores and the latest NAV decalared is ₹41.198 as on 23 Feb 2025 at 3:55 am.

DSP Healthcare Fund Direct - Growth scheme return performance in last 1 year is 15.25%, in last 3 years is 86.24% and 309.77% since scheme launch. The min. SIP amount to invest in this scheme is ₹100.